Toronto – Canadian studies have established that taking antidepressants by women during the early stages of pregnancy does not lead to birth fault in babies. In their research work published in the British Journal of Psychiatry on Thursday, Scientists at Montreal University (Universite de Montreal) and the Centre Hospitalier Universitaire Saint-Justine said the antidepressants, taken by females all through the first 3 months of pregnancy, don’t augment her chances of delivering a baby with birth fault.
The research involved about 2,300 pregnant females, who undergo from some psychiatric chaos prior to pregnancy and took antidepressants during the first 3 months of pregnancy – unstable from 30 to 90 days.
When the scientists studied the infant birth defect data composed from these females, they found that the use of antidepressants didn’t elevate the risk of birth defects in their infants.
They also found that the class of the antidepressants didn’t matter. The scientists concluded that birth fault rates didn’t change whether female took antidepressants during the 1st trimester (first 3 months) of pregnancy or not at all throughout the whole pregnancy period.
In fact, refute antidepressants to women with psychiatric disorders during pregnancy could make them option to alcohol abuse or smoking and thus harm the unborn baby, they observed.